Prolonged Exposure + CPT · vs. Supportive therapy: 30%
GAD (Generalized)
0%
+2.6% vs 2020
vs. Applied relaxation: 48%
Session & Provider Data
Typical Treatment Length
12–16
−2 wks vs decade ago
vs. Psychodynamic: 40–60 sessions
Session Duration
50 min
Standard
Structured format · Homework between sessions
Licensed CBT Providers (US)
0+
+12% growth
APA & state-licensed · Psychology Today verified
Teletherapy Adoption
0%
+42% since 2019
Comparable efficacy to in-person (Lancet, 2021)
Avg. Cost Per Session
$150
+8% annual
With insurance: $20–50 copay
Insurance Coverage Rate
0%
+6% since MHPAEA
Mental Health Parity Act mandate
Patient Outcomes
Relapse Prevention (2yr)
0%
vs 70% medication-only
CBT teaches lasting skills · Lower relapse than meds alone
Symptom Reduction (12wk)
0%
Measured by PHQ-9 / GAD-7
Clinically significant change threshold met
Patient Satisfaction
0%
+3.5% vs avg therapy
Would recommend to a friend
Treatment Completion
0%
+8% with structured format
vs. Unstructured therapy: 45%
Maintenance at 1 Year
0%
Sustained gains
With booster sessions: 78%
Work Absenteeism Reduction
0%
Significant ROI
WHO workplace mental health data
WHO Endorsed
First-line treatment for anxiety & depression globally
3.5:1 ROI
Return on investment per dollar spent on CBT (WHO, 2023)
0 Side Effects
Physical side effects — unlike pharmacological alternatives
CBT vs. Industry Average
Response Rate
CBT
75%
Avg
52%
Symptom Reduction
CBT
65%
Avg
42%
Sessions to Effect
CBT
12
Avg
26
Satisfaction Score
CBT
82%
Avg
68%
Relapse (2yr)
CBT
30%
Avg
60%
Data aggregated from NIMH, WHO, APA, and peer-reviewed meta-analyses. Updated quarterly. This dashboard is for informational purposes only and does not constitute medical advice. Consult a licensed provider for personal treatment decisions.
Get This Dashboard Weekly
Key therapy metrics, updated research, and practical insights — every Tuesday.
You're on the list.
First update hits your inbox Tuesday.
Join 2,840 readers · No spam · Unsubscribe anytime